InvestorsHub Logo

mick

06/08/20 9:01 PM

#5 RE: mick #4

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation. InvestorsHub NewsWire - 6/8/2020 8:30:00 AM
A